Hostname: page-component-77c78cf97d-tlp4c Total loading time: 0 Render date: 2026-04-24T09:52:40.528Z Has data issue: false hasContentIssue false

Investigation of the effect of serotonin-activated semen washing medium on sperm motility at the molecular level: a pilot study

Published online by Cambridge University Press:  11 November 2024

Elnaz Moshfeghi
Affiliation:
Department of Molecular Biology and Genetics, Yildiz Technical University, Istanbul, Turkey
Yasemin Yilmazer
Affiliation:
Department of Molecular Biology and Genetics, Istanbul Sabahattin Zaim University, Istanbul, Turkey
Sinem Dogan
Affiliation:
Department of Gynecology, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey
Turgut Aydin
Affiliation:
Department of Gynecology, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey
Necati Findikli
Affiliation:
IVF Laboratory, Erasme Hospital, Brussels, Belgium
Tulin Ozbek*
Affiliation:
Department of Molecular Biology and Genetics, Yildiz Technical University, Istanbul, Turkey
*
Corresponding author: Tulin Ozbek; Email: ozbektulin@gmail.com
Rights & Permissions [Opens in a new window]

Summary

In Assisted Reproductive Technologies (ART), efficient sperm preparation is vital for successful fertilization, with washing media enhancing the process. This pilot study examines the molecular-level impact of a new serotonin-containing sperm-washing medium (Prototype) on sperm motility and ROS metabolism, comparing it with commercially available media (Origio and Irvine). Semen samples from thirty-one individuals underwent preparation using the swim-up method post-semen analysis. Each sample was separately washed with the Prototype, Origio and Irvine mediums. ROS formation was determined through flow cytometric, and AT2R and PRDX2 protein levels, associated with sperm motility, were assessed via Western blot. Statistical evaluation compared the findings among the three outlined media. Significant differences were found among three washing media in terms of total and progressive motility. The Prototype medium showed the highest increase in both total (66%) and progressive motility (59%), while the control group exhibited the lowest increases (41% and 27.7%, respectively). Regarding ROS levels, the prototype (11.5%) and Origio (10.7%) groups demonstrated a notable decrease, contrasting with Irvine (25.8%). Molecular assessment revealed a significant elevation in AT2R protein levels in the prototype medium (59%), compared to other media. Additionally, an increase in PRDX2 protein levels was observed in the prototype medium, although this didn’t reach statistical significance. Serotonin-activated washing media for sperm preparation can be a suitable choice for selecting high-quality sperm in ART. A broader molecular analysis with a larger sample size is required to explore the mechanisms and effectiveness of using a serotonin-containing sperm-washing medium in routine ART.

Information

Type
Research Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press
Figure 0

Table 1. Initial characteristics of the semen samples included in the study

Figure 1

Figure 1. The effects of different washing mediums on sperm motility. (A) Total motility. (B) Progressive motility.

Figure 2

Figure 2. Following a 30-minute incubation at 37°C with DCFH-DA probe, the effects of various mediums on ROS levels were assessed using flow cytometry. (A) A forward and scatter dot plot was employed to identify the relevant population. (B) Histograms were utilized to display the fluorescence of the FITC channel, which measured the intensity of 2′,7′-dichlorofluorescin diacetate H2DCF-DA, a marker proportional to ROS production. An illustrative instance of a ROS experiment conducted on a single sample; (C) A comparison of the mean ROS generation during a 30-minute incubation period in three distinct media. Mean ± standard deviation. *p < 0.05 denotes a statistically significant difference when compared to the control group.

Figure 3

Figure 3. The effects of different washing media on protein expression. (A) Angiotensin II type 2 receptor (AT2R). (B) Peroxiredoxin 2 (PRDX2).